The Future of CAR T Therapeutics to Treat Autoimmune Disorders
Ann‐Christin Pecher(Center for Rheumatology), Jörg Henes(University of Tübingen), Luca Hensen(University Children's Hospital Tübingen), Claudia Lengerke(STZ eyetrial)
Cited by 13
Related Papers
CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome
|JAMA|2023|234
Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers
|Frontiers in Immunology|2018|103
Prevalence of autoimmune disease in women with premature ovarian failure
|The European Journal of Contraception & Reproductive Health Care|2019|77
Evi1 regulates Notch activation to induce zebrafish hematopoietic stem cell emergence
|The EMBO Journal|2016|46